Explore Business Standard
Book Building
₹ -
₹ -
-
₹ -
MumbaiNSE
-
-
-
Initial public offer of up to [*] equity shares of face value of Rs. 5/- each (Equity Shares) of Sai Parenteral's Limited (Company or Issuer) for cash at a price of Rs. [*] per equity share (Including a Share Premium of Rs. [*] Per Equity Share) (Offer Price) aggregating up to Rs. [*] Crore comprising a fresh issue of up to [*] equity shares of face value of Rs. 5 each aggregating up to Rs. 285 Crore by the company (Fresh Issue) and an offer for sale of up to 3,500,000 equity shares of face value of Rs. 5/- each aggregating up to Rs. [*] Crore (Offered Shares) by investor selling shareholders (as Defined Below) (such sale, the Offer For Sale, and together with the fresh issue, theOffer). The offer shall constitute [*]% of the post-offer paid up equity share capital of the company.The face value of equity shares is Rs. 5 each. The offer price is [*] times the face value of the equity shares. The price band and the minimum bid lot will be decided by the company.
Capacity expansion and upgradation of manufacturing facilities. Establishment of a new R&D Centre. Repayment / prepayment of certain outstanding borrowings. Working capital requirements. Investment in wholly owned subsidiary, Sai Parenterals Pte Limited (Singapore), in relation to the proposed acquisition of Noumed Pharmaceuticals Pty Limited (Australia). General corporate purposes.
Sai Parenteral's Ltd, Office No S6-2, Pinnacle Busine.Park, Mahakali Caves Road, Mumbai - 400093
Phone - 91-22-62638200
Fax - 91-22-63638299
Email - cs@saiparenterals.com
Website - https:, www.saiparenterals.com